Johnson & Johnson

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencesource_reported
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

12 directors published. 6 of 7 with a published determination are independent.

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
• OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
• FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
• CompensationNot reviewed. Pay design shows how incentives are governed.
• GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
• Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
• AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
• LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
• RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
• CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
• AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
• Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
• Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
• Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
• Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
• This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

• EF
  Elizabeth ForminardExecutive Vice President, Chief Legal Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:22
• JS
  James SwansonExecutive Vice President, Chief Information Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:23
• JD
  Joaquin DuatoChairman of the Board; Chief Executive Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:24, company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:10
• JJ
  Joseph J. WolkExecutive Vice President, Chief Financial Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:25
• JR
  Joshua ReedExecutive Vice President, Innovative Medicine, R&D
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:26
• KE
  Kathryn E. WengelExecutive Vice President, Chief Technical Operations Risk Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:27
• KM
  Kristen MulhollandExecutive Vice President, Chief Human Resources Officer
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:28
• TS
  Tim SchmidExecutive Vice President, Worldwide Chairman, MedTech
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:29
• VB
  Vanessa BroadhurstExecutive Vice President, Global Corporate Affairs
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:30
• DE
  Daniel E. PintoDirector
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:11
• EA
  Eugene A. WoodsIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:12
• HJ
  Hubert JolyIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:13
• JA
  Jennifer A. DoudnaIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:14
• JG
  John G. MorikisDirector
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:15
• MA
  Marillyn A. HewsonLead Independent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:16
• MA
  Mark A. WeinbergerIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:17
• MB
  Mark B. McClellanDirector
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:18
• MC
  Mary C. BeckerleIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:19
• NY
  Nadja Y. WestDirector
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:20
• PA
  Paula A. JohnsonIndependent Director
  company:087689c5-2312-4fd4-a61b-872e31e73f9a:leadership_role:21

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis

Published company record built from public sources

Sources

19 evidence records cited. 0 with redistribution rights.

Never published

Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry

Record claimed

No

Open disputes

0

Identity ownership

unclaimed

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

1. E1
   Alpha canonical company public projection

   Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 7 Claims.
   Open web
   Rights not recorded, link only
   Evidence not pinned
2. E2
   JOHNSON & JOHNSON Form 10-K (filed 2026-02-11)

   JOHNSON & JOHNSON Form 10-K (filed 2026-02-11). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   JOHNSON & JOHNSON DEF 14A 2026-03-11

   sec proxy. Published Mar 11, 2026. Retrieved Mar 21, 2026. Cited by 7 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   Johnson & Johnson director board source

   sec filing. Published Mar 11, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   Johnson & Johnson director board source

   sec filing. Published Mar 11, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   Johnson & Johnson director board source

   sec filing. Published Mar 11, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   Johnson & Johnson director board source

   sec filing. Published Mar 11, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   Johnson & Johnson director board source

   sec filing. Published Mar 11, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   JNJ executive roster source

   sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
   Authority not assessed
   Rights not recorded, link only
   Evidence not pinned
10. E10
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
11. E11
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
12. E12
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
13. E13
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
14. E14
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
15. E15
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
16. E16
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
17. E17
    JNJ executive roster source

    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
18. E18
    Audit

    board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 35 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
19. E19
    S&P 500

    Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

• Daniel E. Pinto seat on Johnson & Johnson, effective 2025-01-01.
• John G. Morikis seat on Johnson & Johnson, effective 2025-01-01.
• Daniel E. Pinto member of Audit, effective 2025-01-01.
• Audit; Compensation & Benefits committee of Johnson & Johnson, effective 2025-01-01.
• John G. Morikis member of Audit; Compensation & Benefits, effective 2025-01-01.
• Eugene A. Woods seat on Johnson & Johnson, effective 2023-01-01.
• Paula A. Johnson seat on Johnson & Johnson, effective 2023-01-01.
• Compensation & Benefits; Regulatory Compliance & Sustainability; Risk committee of Johnson & Johnson, effective 2023-01-01.
• Eugene A. Woods member of Compensation & Benefits; Regulatory Compliance & Sustainability; Risk, effective 2023-01-01.
• Paula A. Johnson member of Nominating & Corporate Governance; Science & Technology, effective 2023-01-01.
• Joaquin Duato seat on Johnson & Johnson, effective 2022-01-01.
• Joaquin Duato chairs board Johnson & Johnson, effective 2022-01-01.
• Joaquin Duato member of Finance, effective 2022-01-01.
• Nadja Y. West seat on Johnson & Johnson, effective 2020-01-01.
• Nadja Y. West member of Regulatory Compliance & Sustainability; Science & Technology; Risk, effective 2020-01-01.
• Hubert Joly seat on Johnson & Johnson, effective 2019-01-01.
• Marillyn A. Hewson seat on Johnson & Johnson, effective 2019-01-01.
• Marillyn A. Hewson lead independent director of Johnson & Johnson, effective 2019-01-01.
• Mark A. Weinberger seat on Johnson & Johnson, effective 2019-01-01.
• Audit; Nominating & Corporate Governance committee of Johnson & Johnson, effective 2019-01-01.
• Hubert Joly member of Audit; Nominating & Corporate Governance, effective 2019-01-01.
• Nominating & Corporate Governance; Compensation & Benefits; Finance committee of Johnson & Johnson, effective 2019-01-01.
• Marillyn A. Hewson member of Nominating & Corporate Governance; Compensation & Benefits; Finance, effective 2019-01-01.
• Regulatory Compliance & Sustainability; Audit; Risk committee of Johnson & Johnson, effective 2019-01-01.
• Mark A. Weinberger member of Regulatory Compliance & Sustainability; Audit; Risk, effective 2019-01-01.
• Jennifer A. Doudna seat on Johnson & Johnson, effective 2018-01-01.
• Nominating & Corporate Governance; Science & Technology committee of Johnson & Johnson, effective 2018-01-01.
• Jennifer A. Doudna member of Nominating & Corporate Governance; Science & Technology, effective 2018-01-01.
• Mary C. Beckerle seat on Johnson & Johnson, effective 2015-01-01.
• Science & Technology; Regulatory Compliance & Sustainability; Risk committee of Johnson & Johnson, effective 2015-01-01.
• Mary C. Beckerle member of Science & Technology; Regulatory Compliance & Sustainability; Risk, effective 2015-01-01.
• Mark B. McClellan seat on Johnson & Johnson, effective 2013-01-01.
• Regulatory Compliance & Sustainability; Science & Technology; Risk committee of Johnson & Johnson, effective 2013-01-01.
• Mark B. McClellan member of Regulatory Compliance & Sustainability; Science & Technology; Risk, effective 2013-01-01.